BNP Paribas Financial Markets’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-188,208
| Closed | -$31.1M | – | 4150 |
|
|
2021
Q2 | $31.1M | Sell |
188,208
-93,301
| -33% | -$15.6M | 0.04% | 461 |
|
|
2021
Q1 | $43.2M | Buy |
281,509
+257,134
| +1,055% | +$34.9M | 0.06% | 311 |
|
|
2020
Q4 | $3.06M | Buy |
24,375
+16,630
| +215% | +$1.86M | 0.01% | 1406 |
|
|
2020
Q3 | $786K | Sell |
7,745
-1,353
| -15% | -$138K | ﹤0.01% | 1941 |
|
|
2020
Q2 | $885K | Buy |
9,098
+5,822
| +178% | +$542K | ﹤0.01% | 1859 |
|
|
2020
Q1 | $272K | Sell |
3,276
-8,056
| -71% | -$786K | ﹤0.01% | 2693 |
|
|
2019
Q4 | $1.26M | Sell |
11,332
-65,081
| -85% | -$6.69M | ﹤0.01% | 1909 |
|
|
2019
Q3 | $7.58M | Buy |
76,413
+76,392
| +363,771% | +$7.59M | 0.01% | 901 |
|
|
2019
Q2 | $2.08K | Sell |
21
-15,145
| -100% | -$1.45M | ﹤0.01% | 4316 |
|
|
2019
Q1 | $1.67M | Buy |
15,166
+14,252
| +1,559% | +$1.49M | ﹤0.01% | 1470 |
|
|
2018
Q4 | $84.1K | Sell |
914
-3,842
| -81% | -$389K | ﹤0.01% | 2454 |
|
|
2018
Q3 | $524K | Buy |
4,756
+848
| +22% | +$88.3K | ﹤0.01% | 2003 |
|
|
2018
Q2 | $365K | Sell |
3,908
-7,075
| -64% | -$609K | ﹤0.01% | 2149 |
|
|
2018
Q1 | $911K | Sell |
10,983
-276
| -2% | -$24.5K | ﹤0.01% | 1805 |
|
|
2017
Q4 | $1.03M | Buy |
11,259
+4,988
| +80% | +$415K | ﹤0.01% | 1962 |
|
|
2017
Q3 | $478K | Sell |
6,271
-31,993
| -84% | -$2.42M | ﹤0.01% | 2014 |
|
|
2017
Q2 | $2.87M | Sell |
38,264
-18,564
| -33% | -$1.29M | 0.01% | 1010 |
|
|
2017
Q1 | $3.71M | Buy |
56,828
+55,720
| +5,029% | +$3.28M | 0.01% | 855 |
|
|
2016
Q4 | $61.1K | Sell |
1,108
-985
| -47% | -$54.1K | ﹤0.01% | 2739 |
|
|
2016
Q3 | $118K | Buy |
2,093
+1,144
| +121% | +$56.1K | ﹤0.01% | 2021 |
|
|
2016
Q2 | $39.6K | Buy |
+949
| New | +$43.7K | ﹤0.01% | 2363 |
|
|
2016
Q1 | – | Sell |
-3,710
| Closed | -$168K | – | 3249 |
|
|
2015
Q4 | $168K | Sell |
3,710
-430
| -10% | -$18.1K | ﹤0.01% | 2048 |
|
|
2015
Q3 | $161K | Buy |
4,140
+2,485
| +150% | +$99.5K | ﹤0.01% | 2099 |
|
|
2015
Q2 | $60.1K | Buy |
1,655
+1,197
| +261% | +$37.9K | ﹤0.01% | 2376 |
|
|
2015
Q1 | $13.2K | Buy |
+458
| New | +$12.8K | ﹤0.01% | 2591 |
|
Other funds holding PRAH
BNP Paribas Financial Markets's PRAH Position: Q3 2021 in Review
BNP Paribas Financial Markets sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 188,208 shares — an estimated $31.1M sold.
BNP Paribas Financial Markets first reported a position in PRAH in Q1 2015 and held it in 25 quarters. The position peaked at $43.2M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- BNP Paribas Financial Markets reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- BNP Paribas Financial Markets sold 188,208 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $31.1M.
- BNP Paribas Financial Markets first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 25 quarters.
- BNP Paribas Financial Markets's PRA Health Sciences, Inc. position peaked at $43.2M in Q1 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2021, filed 12 Nov 2021.